| Danielle Morse, | |
|
100 Cummings Ctr Ste 136p, Beverly, MA 01915 | |
| (978) 279-0800 | |
| Not Available |
| Full Name | Danielle Morse |
|---|---|
| Gender | Female |
| Speciality | Family Practice |
| Experience | 8 Years |
| Location | 100 Cummings Ctr Ste 136p, Beverly, Massachusetts |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1851753867 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | 278057 (Massachusetts) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Partners Healthcare At Home - Home Care | Waltham, MA | Home health agency |
| North Shore Medical Center - | Salem, MA | Hospital |
| Massachusetts General Hospital | Boston, MA | Hospital |
| Northeast Hospital Corporation | Beverly, MA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| North Shore Physicians Group Inc | 3577467224 | 488 |
News Archive
Patients with high blood pressure are benefiting from the expanded role played by pharmacists in Alberta, according to a new study from the University of Alberta's Faculty of Medicine & Dentistry.
A new study in the Journal of Cell Biology identifies a cytokine signaling pathway that induces the breakdown of disused skeletal muscle. Blocking this pathway could prevent immobilized patients from losing their muscle tissue.
Jennerex, Inc., a private clinical-stage biotherapeutics company focused on the development and commercialization of first-in-class targeted oncolytic virus products for cancer, together with its international commercialization partners, today announced that enrollment has been initiated and the first patient has been randomized in a Phase 2b clinical trial called TRAVERSE.
Covidien, a leading global provider of healthcare products, today announced that the U.S. Food and Drug Administration (FDA) has approved the EverFlex Self-Expanding Peripheral Stent System for use in the superficial femoral artery (SFA) and/or the proximal popliteal artery.
› Verified 5 days ago
| Entity Name | North Shore Physicians Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1588606123 PECOS PAC ID: 3577467224 Enrollment ID: O20050429000668 |
News Archive
Patients with high blood pressure are benefiting from the expanded role played by pharmacists in Alberta, according to a new study from the University of Alberta's Faculty of Medicine & Dentistry.
A new study in the Journal of Cell Biology identifies a cytokine signaling pathway that induces the breakdown of disused skeletal muscle. Blocking this pathway could prevent immobilized patients from losing their muscle tissue.
Jennerex, Inc., a private clinical-stage biotherapeutics company focused on the development and commercialization of first-in-class targeted oncolytic virus products for cancer, together with its international commercialization partners, today announced that enrollment has been initiated and the first patient has been randomized in a Phase 2b clinical trial called TRAVERSE.
Covidien, a leading global provider of healthcare products, today announced that the U.S. Food and Drug Administration (FDA) has approved the EverFlex Self-Expanding Peripheral Stent System for use in the superficial femoral artery (SFA) and/or the proximal popliteal artery.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Danielle Morse, 100 Cummings Ctr Ste 136p, Beverly, MA 01915-6127 Ph: (978) 279-0800 | Danielle Morse, 100 Cummings Ctr Ste 136p, Beverly, MA 01915 Ph: (978) 279-0800 |
News Archive
Patients with high blood pressure are benefiting from the expanded role played by pharmacists in Alberta, according to a new study from the University of Alberta's Faculty of Medicine & Dentistry.
A new study in the Journal of Cell Biology identifies a cytokine signaling pathway that induces the breakdown of disused skeletal muscle. Blocking this pathway could prevent immobilized patients from losing their muscle tissue.
Jennerex, Inc., a private clinical-stage biotherapeutics company focused on the development and commercialization of first-in-class targeted oncolytic virus products for cancer, together with its international commercialization partners, today announced that enrollment has been initiated and the first patient has been randomized in a Phase 2b clinical trial called TRAVERSE.
Covidien, a leading global provider of healthcare products, today announced that the U.S. Food and Drug Administration (FDA) has approved the EverFlex Self-Expanding Peripheral Stent System for use in the superficial femoral artery (SFA) and/or the proximal popliteal artery.
› Verified 5 days ago
Gregory Snyder, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 38r Enon St, Beverly, MA 01915 Phone: 978-927-7727 Fax: 978-927-4598 | |
Dr. Mavis Webster Jaworski, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 25 Hale St, Floor 1, Beverly, MA 01915 Phone: 978-921-5885 | |
Susan M Deluca, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 900 Cummings Ctr, Suite 126v, Beverly, MA 01915 Phone: 978-279-0800 Fax: 978-279-0805 | |
Dr. Tina Waugh, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 38r Enon St, Beverly, MA 01915 Phone: 978-927-7727 Fax: 978-927-4598 | |
Neeraj Mahajan, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: Lahey Health Primary Care, Beverly, 30 Tozar Road, Beverly, MA 01915 Phone: 978-927-7727 | |
Spencer R Amesbury, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 900 Cummings Ctr, Suite 218u, Beverly, MA 01915 Phone: 978-922-3622 | |
Dr. Thomas A Groblewski, DO Family Medicine Medicare: Medicare Enrolled Practice Location: 38 Hayes Ave, Beverly, MA 01915 Phone: 978-969-2560 |